However, it is especially the ability of both cancer forms to trigger the pre-osteoblastic cells to express high levels of receptor activator of nuclear factor kappa-Β ligand (RANKL) and low levels of osteoprotegerin (OPG) that boosts the formation of osteoclasts [16]. This evidence concerns the gene TNFRSF11B and cancer.